Despite dozens of high quality trials, mechanistic studies, and widespread generic availability, there remains great resistance to oral statins to reduce the risk of athersclerotic cardiovascular risk (myocardial infarction, stroke, need for revascularization, and cardiovascular death). Alter AI assisted with …
The post What is the Smallest Worthwhile Difference in Cardiovascular Risk? appeared first on Global Research.